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An unusual yet strongly 
conserved flavoprotein reductase 
in bacteria and mammals 
THE TRANSFER of reducing equiv- 
alents between enzymes and the elec- 
tron-carrier cofactors NAD* and NADP ÷ 
is integral to many metabolic reactions. 
While in some instances electrons are 
transferred directly between the sub- 
strate and the nicotinamide cofactor 
(as with alcohol dehydrogenase and 
dihydrofolate reductase), often a bound 
coenzyme serves as an intermediate in 
electron transfer. Enzymes utilize a var- 
iety of such intermediates, including 
heine, iron-sulfur clusters, flavins, and 
more rarely, pteridines. Of this group, 
fiavins such as flavin mononucleotide 
(FMN) and flavin adenine dinucleotide 
(FAD) are the most common. 
Ravoproteins can be divided into at 
least five classes, based upon the 
reaction catalysed and the electron 
acceptor ~,2. Transhydrogenases and 
electron translerases are two classes of 
flavoproteins in which the electron 
acceptor (or donor) is either another 
redox protein or a nicotinamide cofac- 
tot. Members of these two classes are 
distinguished from other flavoproteins 
by their limited reactivity with molecu- 
lar oxygen (05). Transhydrogen~es and 
electron transferases are often associ- 
ated with energy-generating electron 
transport pathways, and the associated 
redox protein is often a 1-electron 
acceptor, such as a cytochrome or a 
non-heme iron-sulfur protein. Well-char- 
acterized examples of flavoprotein 
transhydrogenases include ferredox- 
in-NADP" reductase and glutathione 
reductase; electron transferases are 
typified by the flavodoxins. The flavo- 
protein that is the subject of this review 
is unusual in that it contains both a 
transhydrogenase domain and an elec- 
tron transferase domain on a single 
polypeptide, and thereby represents a 
fusion of two normally independent 
flavoproteins. This compound flavopro- 
tein, first characterized as microsomal 
cytochrome P-450 reductase, has now 
been shown to be a component of two 
bacterial enzymes: a Bacillus megaterium 
cytochrome P-450 and sulfite reductase. 
Cytochrome P.450 reductase 
NADPH-cytochrome P-450 reductase 
is a 78 kDa flavoprotein bound to the 
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The recent determination of the amino acid sequences of the Bacillus 
megaterium cytochrome P-450 and the flavoprotein component of 
Salmonella typhimurium NADPH-sulfite reductase revealed that these 
enzymes contain a flavoptotein moiety remarkably similar to mammalian 
NADPH-cytochrome P-450 reductase. The presence of this oxidore- 
ductase in these very different enzymes suggests that this flavoprotein 
arose early in evolution and was utilized as an enzymological building 
block. The multi-domain structure of the reductase further suggests that it 
arose through a fusion of genes encoding simple flavin electron-transport 
proteins. 
endoplasmic reticulum of most eukary- 
otic cells. As an essential component of 
the microsomal cytochrome P-450- 
dependent monooxygenase system 3,4, 
it catalyses the transfer of electrons 
from NADPH to the cytochromes P-450, 
which are responsible for the oxidation 
of innumerable foreign and endogenous 
compounds including drugs, plant 
metabolites, steroids and prosta- 
glandins (for review see Ref. 5). A most 
notable aspect of cytochrome P-450 
reductase is its flavin content: the 
single polypeptide chain binds both an 
FMN and an FAD prosthetic group 6. As 
established by Vermilion et al. 7, the 
pathway of electron transfer proceeds 
from NADPH to FAD to FMN to 
cytochrome P-450. 
The microsomal cytochrome P-450 
system differs from known bacterial 
and adrenal mitochondrial P-450 
monooxygenase systems in the path- 
way of electron transfer. The bacterial 
and mitochondrial systems use two 
separate electron transfer components: 
an FAD-containing reductase, which 
accepts two reducing equivalents from 
a nicotinamide cofactor (NADPH or 
NADH), and a small iron-sulfur protein 
(a ferredoxin), which catalyses two 
separate l-electron transfers from 
the reductase to cytochrome P-450. 
Although the evolutionary origin of 
microsomal cytochrome P-450 re- 
ductase appears to be distinct from that 
of these two-component electron trans- 
port chains, it is related in function, 
and may be derived from a common 
ancestral pathway. 
Structure. The sequence of P-450 
reductase was first determined for the 
raP, and is now known for a variety of 
species, including humans 9-~4. The 
mammalian reductases share about 
90?/0 sequence identity, with lesser simi- 
larity to the trout (79%) n and yeast 
(33%) ~2 enzymes. A detailed analysis of 
the reductase amino acid sequence, 
with comparison to flavoproteins of 
known three-dimensional structure, has 
facilitated identification of the flavin- 
and cofactor.binding domains of the en- 
zyme Is. A cartoon representation of the 
proposed reductase organization is 
shown in Fig. I. The protein is anchored 
to the endoplasmic reticulum by a 
short hydrophobic amino-terminal seg- 
ment; the subsequent catalytic portion 
of the reductase begins with a 150- 
residue segment that shows consider- 
able similarity to the bacterial flavo- 
doxins. 
Ravodoxins are small (15-23 kDa), 
acidic, FMN-containing proteins found 
in bacteria and algae, but not in higher 
plants or animals. Flavodoxins are 
strict electron transferases, reacting 
only with other redox proteins, and are 
able to replace ferredoxins in many 
redox pathways (for review see Ref. 16). 
The three-dimensional structures of 
several flavodoxins are known. 
Cytochrome P-450 reductase exhibits 
several regions of strong sequence simi- 
larity with these fiavoproteins, most 
notably with the Desulfovibrio pulgaris 
fiavodoxin, which correspond to seg- 
ments involved in binding the FMN 
group to these proteins. Moreover, the 
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predicted secondary structure of this 
region of the reductase, obtained by the 
method of Chou and Fasman, is very 
similar to the secondary structure of 
the flavodoxins, suggesting that this 
region of the reductase binds FMN in an 
overall configuration like that of flavo- 
doxin, despite being incorporated into 
a much larger protein TM. 
Recent studies utilizing site-directed 
mutagenesis have supported this 
hypothesis ~7. In flavodoxins there are 
two residues, which are usually 
hydrophobic and often aromatic, that 
are located above and below the FMN 
isoalloxazine ring. These shielding 
residues maintain a hydrophobic en- 
vironment for the flavin, and may par- 
ticipate in pi-pi stacking interactions 
with the isoalloxazine ring ~6. In P-450 
reductase, the proposed flavin-shielding 
residues are Tyrl40 and Tyr178 (Ref. 
15). Substitution of aspartate for 
Tyrl40, the residue proposed to be 
positioned at an angle of 45 ° over the 
interior face of the flavin ring, results in 
a fivefold decrease in reductase activity, 
although it does not significantly alter 
RVlN binding. In contrast, substitution 
of aspartate for Tyr178, the proposed 
exterior ring-shielding residue, coplanar 
with the flavin ring in flavodoxin, abol- 
ishes both reductase activity and FMN 
binding. Replacement of either, or both, 
tyrosines with phenylalanine, an obvi- 
ously conservative replacement, does 
not affect activity or FMN binding. 
Interestingly, FAD binding is reduced by 
the Tyr178~Asp mutation, which may 
indicate that FAD incorporation is 
dependent on formation of an intact 
FMN domain. These results provide 
strong support for the hypothesis that 
this region of P-450 reductase binds the 
FMN prosthetic group. Although the 
corresponding mutations have not yet 
been examined in a flavodoxin molecule 
per se, the effects described above are 
consistent with the FMN being bound in 
a manner similar to that found in the 
fiavodoxins. 
Cytochrome P-450 reductase also 
exhibits significant sequence similarity 
to two FAD-containing enzymes, ferre- 
doxin-NADP ÷ reductase and NADH- 
cytochrome b5 reductase ~s. Both of 
these enzymes are simple transhy- 
drogenase-type flavoproteins, catalysing 
electron transfer between a nicotina- 
mide cofactor and a l-electron ac- 
ceptor (or donor) protein. Ferredoxin 
reductase is the terminal electron car- 
rier of the photosynthetic electron 
transport chain, and cytochrome b5 
reductase is a component of 
the microsomal fatty acid 
desaturase and elongation 
pathways, and also a com- 
ponent of the methe- 
moglobin reductase path- 
way in red blood cells. The 
similarity between P-450 
reductase and these two 
flavoproteins begins approx- 
imately 40 residues beyond 
the FMN-binding domain, 
and extends for approxi- 
mately 60 residues before 
being disrupted by a ll7- 
amino acid segment in P-450 
reductase that appears unre- 
lated to these two flavopro- 
teins. Following this 'inser- 
tion', the sequence similari- 
ty resumes, and becomes strongest 
in the carboxy-terminal region of the 
proteins. By comparison of these 
sequences to glutathione reductase, an 
FAD-containing protein whose three- 
dimensional structure is known, tenta- 
tive assignments of FAD- and NADPH- 
binding domains have been made ~s. 
The initial 60-amino acid segment of 
similarity has been proposed as the 
FAD pyrophosphate-binding segment, 
and the subsequent l l7-amino acid 
insertion in P-450 reductase has been 
proposed as being involved in orienting 
the two flavin domains for !nterflavin 
electron transport. Because ferredoxin 
reductase and cytochrome bs reductase 
contain only a single flavin, this orient- 
ing segment would be unnecessary in 
these enzymes. The proposed nico- 
tinamide cofactor-binding domain 
begins at approximately position 480 of 
P-450 reductase, and extends for 
approximately 200 residues. The se- 
quence similarity among these proteins 
in this region is strong, and is supported 
by a variety of chemical modification 
studies that have demonstrated that 
bound cofactor in all three flavopro- 
teins can protect specific residues in 
this region from modification (for ex- 
amples see Refs 14, 18 and 19). These 
results support the assignment of the 
middle and carboxy-terminal segments 
of P-450 reductase to binding FAD and 
NADPH, respectively. 
Evolutionary odglns. The amino-terminal 
homology of P-450 reductase with flavo- 
doxin, and the carboxy-terminal hom- 
ology with ferredoxin-NADP" reductase, 
suggest that P-450 reductase arose 
through a fusion of the ancestral genes 
for these two types of fiavoproteins. It 






Domain organization of cytochrome P-450 reductase. 
The protein is anchored to the endoplasmic reticulum 
by its hydrophobic amino-terminal segment, which is 
followed by the FMN-, FAD- and NADPH-binding 
domains. 
stitute for ferredoxin in a variety of 
pathways, including the photosynthetic 
reduction of NADP ÷ with ferredoxin 
reductase ~s. It has been suggested that 
the genes for flavodoxin and ferredoxin 
reductase were arranged in tandem in 
an operon of an early organism, and at 
some point fused to give rise to the pri- 
mordial P-450 reductase gene~E That 
these two proteins could simply fuse in 
a head-to-tail fashion and yield a func- 
tional protein would be surprising, and 
the additional segment (or insertion) 
discussed earlier may have been necess- 
ary to couple the two proteins effec- 
tively. This segment is predicted to be 
almost entirely a-helical, suggesting 
that it may be located on the surface of 
the protein. 
The recently determined structure of 
the rat P-450 reductase gene supports 
a gene fusion origin for this 
flavoprotein 2°. The gene is divided into 
fifteen coding exons, of which three 
encode the FMN domain and six encode 
the FAD and NADPH domains. The 
beginning and end of the FMN domain 
is clearly coincident with intron pos- 
itions, as is the start of the FAD domain; 
this placement of introns precisely 
between these functional domains sug- 
gests that each was originally a sep- 
arate entity, and that a genetic recombi- 
nation event brought them together and 
gave rise to the reductase as a 'fusion 
protein'. 
Cytochrome P-450 arose over two bil- 
lion years ago, and members of this 
family of monooxygenases are present 
in both prokaryotes and eukaryotes 
(for review see Ref. 21). The earliest 
P-450s were bacterial, and presumably 
utilized the two-component electron 
transport chain (a ferredoxin reductase 
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Sequence alignment of reductases. The flavoprotein moieties of B. megateriurn cytochrome P-450.f,~l 
(Ref. 25) (upper line, BM-3) and S. typhirnurium sulfite reductase 2~ (lower line, SR) are aligned with 
rat cytochrome P-450 reductase 8 (middle line, P450R). Amino acids that match the rat reductase are 
boxed. Note that the P'450eM-Z sequence begins at position 59 of the rat reductase sequence, and 
corresponds to amino acid 461 of the complete P'450BM.3 sequence. The FMN phosphate-binding seg- 
ment is shaded, and the FMN ring-shielding residues are indicated with arrows. The glycine-rich and 
Cys-Gly dipeptide-containing segments in the proposed NADPH domain are also indicated by shading. 
FAD-PPi, proposed FAD pyrophosphate-binding segment. 
and a ferredoxin) discussed earlier. The 
earliest microsomal P-450s arose 1.3 
bill ion years ago, shortly after the 
prokaryotic--eukaryotic divergence, 
and presumably utilized microsomal 
cytochrome P-450 reductase for electron 
input, as all present.day microsomai 
P-450s are dependent upon this flavo- 
protein. Thus the evidence from this 
system suggests that the reductase was 
present in early eukaryotes. The evi- 
dence presented in the next two sec- 
tions indicates that this compound 
flavoprotein almost certainly had 
evolved well before the emergence of 
eukaryotes. 
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Bacillus megaterlum P450 reductase 
Although evolutionary studies indi- 
cate that cytochrome P-450 should be 
present in virtually all organisms, 
including bacteria, its presence in pro- 
karyotes has only been demonstrated 
in a limited number of species to date 
(for review see Ref. 22). As noted above, 
evolutionary studies would also indi- 
cate that bacterial I)-450 systems 
should utilize a two-component elec- 
tron transport chain, rather than the 
compound flavoprotein, cytochrome 
,°-450 reductase. Indeed, all but one of 
the bacterial cytochrome P-450 systems 
so far characterized appear to use a 
ferredoxin reductase/ferre- 
doxin electron transport 
chain; the one exception, 
Bacillus megaterium cyto- 
chrome P-450BM~, is unusual 
in several respects. 
Cytochrome P-450BM~ is a 
119 kDa fatty acid (o-2 
hydroxylase that has been 
characterized in the labora- 
tory of Armand Fulco at 
UCLA 2~-25. Like all bacterial 
P-450s, and in contrast to 
eukaryotic P-450s, P-450s~ 
is a cytosolic rather than 
membrane-bound enzyme; 
unlike all other known P-450 
monooxygenases, it requires 
no additional electron trans- 
port components for ac- 
tivity. This catalytically self- 
sufficient enzyme contains 
1 mole of heme and 1 mole 
each of FMN and FAD on a 
single polypeptide chain. 
The molecular weight and 
prosthetic group content 
suggested that P-450B~ 
might represent a fusion of 
genes corresponding to the 
mammalian P-450 and its 
microsomal reductase ~, a 
supposition that has now 
been confirmed by se- 
quencing the gene zs. 
The protein is divided 
into two discrete domains, 
one of which contains the 
heme group, with the sec- 
ond domain containing FMN 
and FAD 24. The two domains 
are readily separated by lim- 
ited proteolysis, and each 
retains its respective pros- 
thetic group(s) when separ- 
ated. The heme domain of 
P-450,~ exhibits about 25% 
sequence identity with 
mammalian fatty acid hydroxylases, 
and the flavin domain shows about 33% 
identity with mammalian P-450 reduc- 
tases ~s. The two domains are connected 
by approximately 30 amino acids, 
which includes a highly basic segment 
cleaved during limited proteolysis. 
As might be expected, several 
regions of the Bacillus and mammalian 
reductases contain highly conserved 
segments, corresponding to regions 
likely to be involved in flavin binding. 
An alignment of the Bacillus reductase 
sequence with the rat microsomal 
reductase is shown in Fig. 2. In the FMN 
domain, a segment proposed to bind 
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the FMN phosphate group is strongly 
conserved (residues 26-34, shaded in 
Fig. 2), and of the two flavin ring-shield- 
ing residues (indicated by arrows), the 
interior tyrosine (Tyr76) is conserved 
and the exterior tyrosine is replaced by 
tryptophan (Trpll4), an amino acid 
commonly found in this position in 
flavodoxins. The 'insertion' in the FAD 
domain is maintained in the Bacillus 
reductase, and, as with ferredoxin 
reductase and cytochrome b5 re- 
ductase, the sequence similarity is 
strongest in the carboxy-terminal 
region of the protein, the proposed 
NADPH-binding domain. Two especially 
conserved segments in this region are 
noteworthy: a glycine-rich segment, 
suggestive of a pyrophosphate-binding 
loop, found in virtually all nicotinamide 
cofactor-dependent enzymes (residues 
436--450, shaded); and a segment con- 
taining a Cys-Gly dipeptide present in 
all P-450 reductases, and also in ferre- 
doxin reductase and cytochrome bs 
reductase (residues 633-643, shaded). 
Although no function has been assigned 
to this latter segment, a cysteine in cyto- 
chrome bs reductase located nine 
residues away from this conserved 
dipeptide has been shown to be pro- 
tected from chemical modification by 
NADH 19, supporting the assignment of 
nicotinamide cofactor binding to this 
region of these reductases. 
The Bacillus megateriurn P-4508M~ 
thus contradicts two tenets regarding 
cytochrome P-450 monooxygenases: (I) 
that bacterial systems utilize a two 
component, ferredoxin reductase/ferre- 
doxln electron transport chain; and (2) 
that cytochrome P-450 reductase is 
restricted to eukaryotic internal mem- 
branes. The presence of the reductase 
in this bacterium argues that the flavo- 
protein evolved well before eukaryotes 
and prokaryotes diverged, an argument 
supported by the finding of this flavo- 
protein in sulfite reductase, as dis- 
cussed below. 
Sullite reductase 
NADPH-sulfite reductase is a multi- 
meric enzyme that catalyses the six- 
electron reduction of sulfite to sulfide 2s, 
an obligatory step in the biosynthesis 
of cysteine from sulfate in Escherichia 
coli and Salmonella typhimurium. The 
enzyme, extensively characterized in 
the laboratory of Lewis Siegel at Duke 
University, has a subunit structure of 
a8134, in which the eight a-subunits bind 
eight flavin molecules, four each of FMN 
and FAD, and the four ~-subunits each 
contain an Fe4S4 cluster and a siroheme 
group 2~. As in cytochrome P-450 re- 
ductase, each flavin has a distinct role 
in the electron transfer sequence, with 
FAD serving as the entry port for elec- 
trons from NADPH, and FMN serving as 
the exit port to the [5-subuniP. Indeed, 
the studies from Siegel's laboratory on 
the mechanism of electron transfer in 
sulfite reductase served as a model for 
the characterization of P-450 reductase 
by Vermilion et al.~; the recent determi- 
nation of the amino acid sequence 
of the sulfite reductase fiavoprotein has 
revealed the basis for the similarity 
in the mechanism of these two re- 
ductases 29. 
The flavoprotein moiety (a-subunit) 
of sulfite reductase from either S. 
typhimurium or E. coli shows about 30% 
sequence identity with rat cytochrome 
P-450 reductase 29 (see Fig. 2). As with 
the Bacillus megaterium P-450 re- 
ductase, a segment corresponding to 
the fiavodoxin FMN phosphate-binding 
residues is strongly conserved, but, in 
contrast to the Bacillus reductase, only 
the exterior FMN ring-shielding residue 
is conserved (Tyr158); the interior tyro- 
sine is replaced with glutamine 
(Glull9). The 'insertion' in the FAD 
domain, relative to ferredoxin re- 
ductase and cytochrome bs reductase, 
is maintained in sulfite reductase, 
although it is somewhat shorter than in 
the P-450 reductases. As with the 
Bacillus protein, the greatest sequence 
similarity is found in the carboxy-ter- 
minal portion of the protein, corre- 
sponding to the NADPH-binding do- 
main. Notably, the glycine-rich segment 
present in the Bacillus and mammalian 
reductases is highly conserved in sul- 
rite reductase, as is the segment con- 
taining the Cys-Gly dipeptide. Thus, 
despite the great evolutionary distance, 
all three reductases are clearly homolo- 
gous, and all have been strongly con- 
served through evolution. 
Despite the sequence similarity 
between sulfite reductase and P-450 
reductase, the two proteins differ in one 
important respect: the sulfite reductase 
fiavoprotein component, present as an 
octamer of identical a-subunits, binds 
only eight flavin molecules rather than 
the sixteen that would be expected 
based on its homology with P-450 
reductase. As FMN and FAD are present 
in equal proportions, there are various 
scenarios for flavin binding in this com- 
plex: each subunit may bind one flavin 
molecule, either FMN or FAD; or half of 
the subunits may contain a full flavin 
complement (FMN plus FAD), while half 
may lack flavin completely. The actual 
distribution of the fiavin groups is not 
yet known. Siegel's group has proposed 
that two a-subunits are required for 
complete electron transfer, with each 
binding either FMN or FAD, and that for 
each subunit, the binding of one fiavin 
precludes the binding of a second flavin 
to that subunit. How this is ac- 
complished is not yet understood. 
This arrangement raises two ques- 
tions: how is the I:I ratio of FMN- to 
FAD-containing subunits established in 
the octameric complex, and how is 
intersubunit electron transport accom- 
plished? Clearly there must be subtle 
differences between sulfite reductase 
and P-450 reductase that facilitate the 
octameric assembly and electron trans- 
port; one such difference may be the 
substitution of glutamine for tyrosine at 
the interior FMN ring-shielding position, 
as noted earlier. As demonstrated by 
Shen et al.~, mutations at this position 
in P-450 reductase inhibit electron 
transport between the FMN and FAD 
groups without dramatically altering 
FMN binding. Similarly, the presence of 
glutamine at this position in sulfite 
reductase may inhibit intramolecular 
electron transport and oblige the 
enzyme to shuttle electrons between 
the fiavins of complementary subunits. 
Conclusion 
The ability to generate, utilize and 
dispose of reducing equivalents in 
metabolic reactions is an essential life 
process, and almost certainly was 
present in the earliest life forms. The 
universality of electron transfer coen- 
zymes and cofactors (flavins and 
nicotinamide dinucleotides) argues that 
these molecules were utilized in the 
earliest stages of evolution. It is thus 
perhaps not surprising that proteins 
that facilitate the inherent activities of 
these molecules are also evolutionarily 
ancient. Cytochrome P-450 reductase 
represents one such example. As pre- 
sented here, it is a component of three 
evolutionarily remote pathways; 
whether it has been incorporated into 
other electron transport pathways and 
enzymes, in other organisms, remains 
to be seen. The multi-domain structure 
of this enzyme has revealed its evol- 
utionary origins, and raised a wealth of 
questions to be addressed by struc- 
ture--function studies on this unusual 
flavoprotein. Foremost among these 
questions must be the orientation of 
the two flavins, and the mechanism by 
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which electrons are transferred 
between these two prosthetic groups. 
Note added in proof 
The recently determined crystal 
structure of ferredoxin reductase 3° 
strongly supports the predicted domain 
structure of these flavoprotein re- 
ductases. 
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